NEW YORK, Dec. 4—Myriad Genetics and Laboratory Corporation of America Holdings announced Tuesday that LabCorp will be the genomics company’s exclusive sales and distribution partner in the US, and will market the company’s DNA-based  tests to its network of more than 200,000 primary care physician customers.

The marketing alliance covers all four of Myriad’s predictive tests, which detect common mutations in order to assess patient risk for hypertension, cardiovascular disease and certain hereditary cancers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.